Traumatic Injury

  • Borna Relja
  • Johann-Philipp Horstmann
Part of the Experientia Supplementum book series (EXS, volume 108)


Traumatic injury as one of the world’s most relevant but neglected health concerns results in modulated inflammasome activity, which is closely linked to the development of post-injury complications. Cytokine-producing capacity of cells is important for the appropriate immune response to trauma and requires not only synthesis and transcription of inflammasome components but also their activation. Unfortunately, the precise role of inflammasome in trauma is still largely unknown. However, in the following chapter, we provide an overview on the best described inflammasomes in the various settings of trauma, introducing the recent findings on the up-to-date best described NLRP inflammasomes and underlying cytokines in the inflammatory response to trauma.


Trauma Inflammasome SIRS CARS PTI Immunosuppression Stress Outcome 


  1. Adamczak S et al (2012) Inflammasome proteins in cerebrospinal fluid of brain-injured patients as biomarkers of functional outcome: clinical article. J Neurosurg 117:1119–1125. Scholar
  2. Adamczak SE et al (2014) Pyroptotic neuronal cell death mediated by the AIM2 inflammasome. J Cereb Blood Flow Metab 34:621–629. Scholar
  3. Adib-Conquy M, Cavaillon JM (2009) Compensatory anti-inflammatory response syndrome. Thromb Haemost 101:36–47CrossRefPubMedGoogle Scholar
  4. Agostini L et al (2004) NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 20:319–325CrossRefPubMedGoogle Scholar
  5. Allam R, Darisipudi MN, Tschopp J, Anders HJ (2013) Histones trigger sterile inflammation by activating the NLRP3 inflammasome. Eur J Immunol 43:3336–3342. Scholar
  6. Allam R, Kumar SV, Darisipudi MN, Anders HJ (2014) Extracellular histones in tissue injury and inflammation. J Mol Med (Berl) 92:465–472. Scholar
  7. Alper B, Erdogan B, Erdogan MO, Bozan K, Can M (2016) Associations of trauma severity with mean platelet volume and levels of systemic inflammatory markers (IL1beta, IL6, TNFalpha, and CRP). Mediat Inflamm 2016:9894716. Scholar
  8. Amantea D et al (2016) Caspase-1-independent maturation of IL-1beta in ischemic brain injury: is there a role for gelatinases? Mini Rev Med Chem 16:729–737CrossRefPubMedGoogle Scholar
  9. Arend WP, Palmer G, Gabay C (2008) IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev 223:20–38. Scholar
  10. Bauernfeind F, Hornung V (2013) Of inflammasomes and pathogens--sensing of microbes by the inflammasome. EMBO Mol Med 5:814–826. Scholar
  11. Bauernfeind F et al (2011) Inflammasomes: current understanding and open questions. Cell Mol Life Sci 68:765–783. Scholar
  12. Bhan C, Dipankar P, Chakraborty P, Sarangi PP (2016) Role of cellular events in the pathophysiology of sepsis. Inflamm Res 65:853–868. Scholar
  13. Bhatia M, Moochhala S (2004) Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol 202:145–156. Scholar
  14. Bianchi ME (2007) DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 81:1–5. Scholar
  15. Boraschi D, Dinarello CA (2006) IL-18 in autoimmunity: review. Eur Cytokine Netw 17:224–252PubMedGoogle Scholar
  16. Brickler T et al (2016) Nonessential role for the NLRP1 inflammasome complex in a murine model of traumatic brain injury. Mediat Inflamm 2016:6373506. Scholar
  17. Bronkhorst MW, Patka P, Van Lieshout EM (2015) Effects of sequence variations in innate immune response genes on infectious outcome in trauma patients: a comprehensive review. Shock 44:390–396. Scholar
  18. Burckstummer T et al (2009) An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat Immunol 10:266–272. Scholar
  19. Busillo JM, Azzam KM, Cidlowski JA (2011) Glucocorticoids sensitize the innate immune system through regulation of the NLRP3 inflammasome. J Biol Chem 286:38703–38713. Scholar
  20. Cannon AR et al (2016) Effects of mesalamine treatment on gut barrier integrity after burn injury. J Burn Care Res 37:283–292. Scholar
  21. Cavaillon JM, Adib-Conquy M (2006) Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis. Crit Care 10:233. Scholar
  22. Cavaillon JM, Adrie C, Fitting C, Adib-Conquy M (2003) Endotoxin tolerance: is there a clinical relevance? J Endotoxin Res 9:101–107. Scholar
  23. Cerretti DP et al (1992) Molecular cloning of the interleukin-1 beta converting enzyme. Science 256:97–100CrossRefPubMedGoogle Scholar
  24. Chen S, Sun B (2013) Negative regulation of NLRP3 inflammasome signaling. Protein Cell 4:251–258. Scholar
  25. Dagenais M, Skeldon A, Saleh M (2012) The inflammasome: in memory of Dr. Jurg Tschopp. Cell Death Differ 19:5–12. Scholar
  26. de Rivero Vaccari JP et al (2009) Therapeutic neutralization of the NLRP1 inflammasome reduces the innate immune response and improves histopathology after traumatic brain injury. J Cereb Blood Flow Metab 29:1251–1261. Scholar
  27. de Rivero Vaccari JP et al (2012) P2X4 receptors influence inflammasome activation after spinal cord injury. J Neurosci 32:3058–3066. Scholar
  28. de Rivero Vaccari JP, Dietrich WD, Keane RW (2014) Activation and regulation of cellular inflammasomes: gaps in our knowledge for central nervous system injury. J Cereb Blood Flow Metab 34:369–375. Scholar
  29. de Vasconcelos NM, Van Opdenbosch N, Lamkanfi M (2016) Inflammasomes as polyvalent cell death platforms. Cell Mol Life Sci 73:2335–2347. Scholar
  30. Denes A et al (2015) AIM2 and NLRC4 inflammasomes contribute with ASC to acute brain injury independently of NLRP3. Proc Natl Acad Sci U S A 112:4050–4055. Scholar
  31. Dinarello CA (2005) Interleukin-1beta. Crit Care Med 33:S460–S462CrossRefPubMedGoogle Scholar
  32. Dinarello CA (2009) Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 27:519–550. Scholar
  33. Dinarello CA (2011) A clinical perspective of IL-1beta as the gatekeeper of inflammation. Eur J Immunol 41:1203–1217. Scholar
  34. Dinarello CA (2013) Overview of the interleukin-1 family of ligands and receptors. Semin Immunol 25:389–393. Scholar
  35. Dinarello CA, Fantuzzi G (2003) Interleukin-18 and host defense against infection. J Infect Dis 187(Suppl 2):S370–S384. Scholar
  36. Ding Z, Zhang J, Xu J, Sheng G, Huang G (2013) Propofol administration modulates AQP-4 expression and brain edema after traumatic brain injury. Cell Biochem Biophys 67:615–622. Scholar
  37. Dobrovolskaia MA, Vogel SN (2002) Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect 4:903–914CrossRefPubMedGoogle Scholar
  38. Dolinay T et al (2012) Inflammasome-regulated cytokines are critical mediators of acute lung injury. Am J Respir Crit Care Med 185:1225–1234. Scholar
  39. Dong Y et al (2016) Melatonin attenuated early brain injury induced by subarachnoid hemorrhage via regulating NLRP3 inflammasome and apoptosis signaling. J Pineal Res 60:253–262. Scholar
  40. Dostert C et al (2008) Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320:674–677. Scholar
  41. Ertel W et al (1995) Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood 85:1341–1347PubMedGoogle Scholar
  42. Fahy RJ et al (2008) Inflammasome mRNA expression in human monocytes during early septic shock. Am J Respir Crit Care Med 177:983–988. Scholar
  43. Feng L et al (2015) P2X7R blockade prevents NLRP3 inflammasome activation and brain injury in a rat model of intracerebral hemorrhage: involvement of peroxynitrite. J Neuroinflammation 12:190. Scholar
  44. Fernandes-Alnemri T, Yu JW, Datta P, Wu J, Alnemri ES (2009) AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 458:509–513. Scholar
  45. Flach R et al (1999) Relation of ex vivo stimulated blood cytokine synthesis to post-traumatic sepsis. Cytokine 11:173–178. Scholar
  46. Frank MG, Weber MD, Watkins LR, Maier SF (2015) Stress sounds the alarmin: the role of the danger-associated molecular pattern HMGB1 in stress-induced neuroinflammatory priming. Brain Behav Immun 48:1–7. Scholar
  47. Frink M et al (2009) IL-6 predicts organ dysfunction and mortality in patients with multiple injuries. Scand J Trauma Resusc Emerg Med 17:49. Scholar
  48. Galbraith N, Walker S, Galandiuk S, Gardner S, Polk HC Jr (2016) The significance and challenges of monocyte impairment: for the ill patient and the surgeon. Surg Infect 17:303–312. Scholar
  49. Giannoudis PV, Pape HC (2007) Trauma and immune reactivity: too much, or too little immune response? Injury 38:1333–1335. Scholar
  50. Grailer JJ et al (2014) Critical role for the NLRP3 inflammasome during acute lung injury. J Immunol 192:5974–5983. Scholar
  51. Grisanti LA et al (2011) Alpha1-adrenergic receptors positively regulate Toll-like receptor cytokine production from human monocytes and macrophages. J Pharmacol Exp Ther 338:648–657. Scholar
  52. Gurcel L, Abrami L, Girardin S, Tschopp J, van der Goot FG (2006) Caspase-1 activation of lipid metabolic pathways in response to bacterial pore-forming toxins promotes cell survival. Cell 126:1135–1145. Scholar
  53. Halle A et al (2008) The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol 9:857–865. Scholar
  54. Han S et al (2015) ROS-mediated NLRP3 inflammasome activity is essential for burn-induced acute lung injury. Mediat Inflamm:720457.
  55. Hazeldine J, Hampson P, Lord JM (2016) The diagnostic and prognostic value of systems biology research in major traumatic and thermal injury: a review. Burns Trauma 4:33. Scholar
  56. He Q et al (2012) HMGB1 promotes the synthesis of pro-IL-1beta and pro-IL-18 by activation of p38 MAPK and NF-kappaB through receptors for advanced glycation end-products in macrophages. Asian Pac J Cancer Prev 13:1365–1370CrossRefPubMedGoogle Scholar
  57. He Y, Franchi L, Nunez G (2013) TLR agonists stimulate Nlrp3-dependent IL-1beta production independently of the purinergic P2X7 receptor in dendritic cells and in vivo. J Immunol 190:334–339. Scholar
  58. Heizmann O, Koeller M, Muhr G, Oertli D, Schinkel C (2008) Th1- and Th2-type cytokines in plasma after major trauma. J Trauma 65:1374–1378. Scholar
  59. Hoegen T et al (2011) The NLRP3 inflammasome contributes to brain injury in pneumococcal meningitis and is activated through ATP-dependent lysosomal cathepsin B release. J Immunol 187:5440–5451. Scholar
  60. Holloway TL, Nicholson SE, Rani M, Cap AP, Schwacha MG (2016) Toll-like receptor responses are suppressed in trauma ICU patients. J Surg Res 206:139–145. Scholar
  61. Hornung V et al (2009) AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458:514–518. Scholar
  62. Horstmann JP, Marzi I, Relja B (2016) Adrenergic stimulation alters the expression of inflammasome components and interleukins in primary human monocytes. Exp Ther Med 11:297–302. Scholar
  63. Hosseinian N, Cho Y, Lockey RF, Kolliputi N (2015) The role of the NLRP3 inflammasome in pulmonary diseases. Ther Adv Respir Dis 9:188–197. Scholar
  64. Hotchkiss RS, Monneret G, Payen D (2013a) Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis 13:260–268. Scholar
  65. Hotchkiss RS, Monneret G, Payen D (2013b) Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol 13:862–874. Scholar
  66. Hsu LC et al (2008) A NOD2-NALP1 complex mediates caspase-1-dependent IL-1beta secretion in response to Bacillus anthracis infection and muramyl dipeptide. Proc Natl Acad Sci U S A 105:7803–7808. Scholar
  67. Impellizzeri D et al (2017) N-Palmitoylethanolamine-oxazoline (PEA-OXA) as a new therapeutic strategy to control neuroinflammation: neuroprotective effects in experimental models of spinal cord and brain injury. J Neurotrauma.
  68. Islam MN, Bradley BA, Ceredig R (2016) Sterile post-traumatic immunosuppression. Clin Transl Immunol 5:e77. Scholar
  69. Janak JC et al (2017) Urinary biomarkers are associated with severity and mechanism of injury. Shock 47:593–598. Scholar
  70. Janeway CA Jr, Medzhitov R (2002) Innate immune recognition. Annu Rev Immunol 20:197–216. Scholar
  71. Jones HD et al (2014) The NLRP3 inflammasome is required for the development of hypoxemia in LPS/mechanical ventilation acute lung injury. Am J Respir Cell Mol Biol 50:270–280. Scholar
  72. Kamo N et al (2013) ASC/caspase-1/IL-1beta signaling triggers inflammatory responses by promoting HMGB1 induction in liver ischemia/reperfusion injury. Hepatology 58:351–362. Scholar
  73. Keel M et al (1996) Endotoxin tolerance after severe injury and its regulatory mechanisms. J Trauma 41:430–437; discussion 437–438Google Scholar
  74. Kim HY, Kim SJ, Lee SM (2015) Activation of NLRP3 and AIM2 inflammasomes in Kupffer cells in hepatic ischemia/reperfusion. FEBS J 282:259–270. Scholar
  75. Kirchhoff C et al (2009) Early down-regulation of the pro-inflammatory potential of monocytes is correlated to organ dysfunction in patients after severe multiple injury: a cohort study. Crit Care 13:R88. Scholar
  76. Kovarova M et al (2012) NLRP1-dependent pyroptosis leads to acute lung injury and morbidity in mice. J Immunol 189:2006–2016. Scholar
  77. Kuipers MT et al (2012) Ventilator-induced lung injury is mediated by the NLRP3 inflammasome. Anesthesiology 116:1104–1115. Scholar
  78. Kwak A, Lee Y, Kim H, Kim S (2016) Intracellular interleukin (IL)-1 family cytokine processing enzyme. Arch Pharm Res 39:1556–1564. Scholar
  79. Land WG (2013) Transfusion-related acute lung injury: the work of DAMPs. Transfus Med Hemother 40:3–13. Scholar
  80. Latz E, Xiao TS, Stutz A (2013) Activation and regulation of the inflammasomes. Nat Rev Immunol 13:397–411. Scholar
  81. Lebel-Binay S et al (2000) Interleukin-18: biological properties and clinical implications. Eur Cytokine Netw 11:15–26PubMedGoogle Scholar
  82. Leentjens J, Kox M, van der Hoeven JG, Netea MG, Pickkers P (2013) Immunotherapy for the adjunctive treatment of sepsis: from immunosuppression to immunostimulation. Time for a paradigm change? Am J Respir Crit Care Med 187:1287–1293. Scholar
  83. Lendemans S et al (2007) Toll-like receptor 2 and 4 expression after severe injury is not involved in the dysregulation of the innate immune system. J Trauma 63:740–746. Scholar
  84. Li J et al (2016) Minocycline protects against NLRP3 inflammasome-induced inflammation and P53-associated apoptosis in early brain injury after subarachnoid hemorrhage. Mol Neurobiol 53:2668–2678. Scholar
  85. Lin WP et al (2016) Heme oxygenase-1 promotes neuron survival through down-regulation of neuronal NLRP1 expression after spinal cord injury. J Neuroinflammation 13:52. Scholar
  86. Liu HD et al (2013) Expression of the NLRP3 inflammasome in cerebral cortex after traumatic brain injury in a rat model. Neurochem Res 38:2072–2083. Scholar
  87. Liu T et al (2016) Blocking triggering receptor expressed on myeloid cells-1 attenuates lipopolysaccharide-induced acute lung injury via inhibiting NLRP3 inflammasome activation. Sci Rep 6:39473. Scholar
  88. Long H, Xu B, Luo Y, Luo K (2016) Artemisinin protects mice against burn sepsis through inhibiting NLRP3 inflammasome activation. Am J Emerg Med 34:772–777. Scholar
  89. Lu B et al (2012) Novel role of PKR in inflammasome activation and HMGB1 release. Nature 488:670–674. Scholar
  90. Ma J, Dong Z, Li QG, Wang JR (2009) Protective effect of propofol against intracerebral hemorrhage injury in rats. Yao Xue Xue Bao 44:344–349PubMedGoogle Scholar
  91. Ma J et al (2016) Propofol inhibits NLRP3 inflammasome and attenuates blast-induced traumatic brain injury in rats. Inflammation 39:2094–2103. Scholar
  92. Manson J, Thiemermann C, Brohi K (2012) Trauma alarmins as activators of damage-induced inflammation. Br J Surg 99(Suppl 1):12–20. Scholar
  93. Marik PE, Flemmer M (2012) The immune response to surgery and trauma: implications for treatment. J Trauma Acute Care Surg 73:801–808. Scholar
  94. Martinon F, Burns K, Tschopp J (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 10:417–426CrossRefGoogle Scholar
  95. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440:237–241. Scholar
  96. Martinon F, Mayor A, Tschopp J (2009) The inflammasomes: guardians of the body. Annu Rev Immunol 27:229–265. Scholar
  97. Maslanik T et al (2013) The inflammasome and danger associated molecular patterns (DAMPs) are implicated in cytokine and chemokine responses following stressor exposure. Brain Behav Immun 28:54–62. Scholar
  98. Matzinger P (2002) The danger model: a renewed sense of self. Science 296:301–305. Scholar
  99. Meisner M, Adina H, Schmidt J (2006) Correlation of procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients. Crit Care 10:R1. Scholar
  100. Mendes ME et al (2011) Differential expression of toll-like receptor signaling cascades in LPS-tolerant human peripheral blood mononuclear cells. Immunobiology 216:285–295. Scholar
  101. Menzel CL et al (2011) Caspase-1 is hepatoprotective during trauma and hemorrhagic shock by reducing liver injury and inflammation. Mol Med 17:1031–1038. Scholar
  102. Miao EA et al (2010) Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat Immunol 11:1136–1142. Scholar
  103. Minutoli L et al (2016) ROS-mediated NLRP3 inflammasome activation in brain, heart, kidney, and testis ischemia/reperfusion injury. Oxidative Med Cell Longev 2016:2183026. Scholar
  104. Mizushima Y, Ueno M, Idoguchi K, Ishikawa K, Matsuoka T (2009) Fever in trauma patients: friend or foe? J Trauma 67:1062–1065. Scholar
  105. Mommsen P et al (2009) Elevated systemic IL-18 and neopterin levels are associated with posttraumatic complications among patients with multiple injuries: a prospective cohort study. Injury 40:528–534. Scholar
  106. Munoz C et al (1991) Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 88:1747–1754. Scholar
  107. Muruve DA et al (2008) The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 452:103–107. Scholar
  108. Netea MG et al (2009) Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood 113:2324–2335. Scholar
  109. Oberholzer A et al (2000) Sepsis after severe injury interrupts caspase-dependent processing of interleukin-18. J Trauma 49:11–16; discussion 16–17Google Scholar
  110. Osuka A, Hanschen M, Stoecklein V, Lederer JA (2012) A protective role for inflammasome activation following injury. Shock 37:47–55. Scholar
  111. Osuka A, Ogura H, Ueyama M, Shimazu T, Lederer JA (2014) Immune response to traumatic injury: harmony and discordance of immune system homeostasis. Acute Med Surg 1(6):63–69CrossRefPubMedPubMedCentralGoogle Scholar
  112. Pape HC et al (2007) Assessment of the clinical course with inflammatory parameters. Injury 38:1358–1364. Scholar
  113. Pfeifer R, Tarkin IS, Rocos B, Pape HC (2009) Patterns of mortality and causes of death in polytrauma patients--has anything changed? Injury 40:907–911. Scholar
  114. Proell M, Gerlic M, Mace PD, Reed JC, Riedl SJ (2013) The CARD plays a critical role in ASC foci formation and inflammasome signalling. Biochem J 449:613–621. Scholar
  115. Puren AJ, Fantuzzi G, Dinarello CA (1999) Gene expression, synthesis, and secretion of interleukin 18 and interleukin 1beta are differentially regulated in human blood mononuclear cells and mouse spleen cells. Proc Natl Acad Sci U S A 96:2256–2261CrossRefPubMedPubMedCentralGoogle Scholar
  116. Rathinam VA, Fitzgerald KA (2016) Inflammasome complexes: emerging mechanisms and effector functions. Cell 165:792–800. Scholar
  117. Reikeras O (2010) Immune depression in musculoskeletal trauma. Inflamm Res 59:409–414. Scholar
  118. Relja B et al (2015) Nlrp1 inflammasome is downregulated in trauma patients. J Mol Med (Berl) 93:1391–1400. Scholar
  119. Roetman B et al (2008) Elevated systemic interleukin-18 in multiple injured patients is not related to clinical outcome. J Interf Cytokine Res 28:741–747. Scholar
  120. Schroder K, Tschopp J (2010) The inflammasomes. Cell 140:821–832. Scholar
  121. Sperry JL et al (2008) Male gender is associated with excessive IL-6 expression following severe injury. J Trauma 64:572–578; discussion 578–579. doi:
  122. Spolarics Z et al (2003) Depressed interleukin-12-producing activity by monocytes correlates with adverse clinical course and a shift toward Th2-type lymphocyte pattern in severely injured male trauma patients. Crit Care Med 31:1722–1729. Scholar
  123. Stanojcic M et al (2014) Leukocyte infiltration and activation of the NLRP3 inflammasome in white adipose tissue following thermal injury. Crit Care Med 42:1357–1364. Scholar
  124. Starzl R et al (2015) Cardiac arrest disrupts caspase-1 and patterns of inflammatory mediators differently in skin and muscle following localized tissue injury in rats: insights from data-driven modeling. Front Immunol 6:587. Scholar
  125. Sun Q et al (2013) Caspase 1 activation is protective against hepatocyte cell death by up-regulating beclin 1 protein and mitochondrial autophagy in the setting of redox stress. J Biol Chem 288:15947–15958. Scholar
  126. Sun Q et al (2017) Redox-dependent regulation of hepatocyte absent in melanoma 2 inflammasome activation in sterile liver injury in mice. Hepatology 65:253–268. Scholar
  127. The global burden of disease (2013) World Health Organization.
  128. Tomura S, de Rivero Vaccari JP, Keane RW, Bramlett HM, Dietrich WD (2012) Effects of therapeutic hypothermia on inflammasome signaling after traumatic brain injury. J Cereb Blood Flow Metab 32:1939–1947. Scholar
  129. van de Veerdonk FL, Netea MG, Dinarello CA, Joosten LA (2011) Inflammasome activation and IL-1beta and IL-18 processing during infection. Trends Immunol 32:110–116. Scholar
  130. van Griensven M (2014) Cytokines as biomarkers in polytraumatized patients. Unfallchirurg 117:699–702. Scholar
  131. Vande Walle L, Lamkanfi M (2016) Pyroptosis. Curr Biol 26:R568–R572. Scholar
  132. Vigano E, Mortellaro A (2013) Caspase-11: the driving factor for noncanonical inflammasomes. Eur J Immunol 43:2240–2245. Scholar
  133. Vladimer GI, Marty-Roix R, Ghosh S, Weng D, Lien E (2013) Inflammasomes and host defenses against bacterial infections. Curr Opin Microbiol 16:23–31. Scholar
  134. Wafaisade A et al (2011) Epidemiology and risk factors of sepsis after multiple trauma: an analysis of 29,829 patients from the Trauma Registry of the German Society for Trauma Surgery. Crit Care Med 39:621–628. Scholar
  135. Wanner GA et al (1996) Liver ischemia and reperfusion induces a systemic inflammatory response through Kupffer cell activation. Shock 5:34–40CrossRefPubMedGoogle Scholar
  136. Wawrocki S, Druszczynska M, Kowalewicz-Kulbat M, Rudnicka W (2016) Interleukin 18 (IL-18) as a target for immune intervention. Acta Biochim Pol 63:59–63. Scholar
  137. Wegiel B, Hauser CJ, Otterbein LE (2015) Heme as a danger molecule in pathogen recognition. Free Radic Biol Med 89:651–661. Scholar
  138. Wen AQ et al (2010) Clinical relevance of IL-1beta promoter polymorphisms (−1470, −511, and −31) in patients with major trauma. Shock 33:576–582. Scholar
  139. Weng X et al (2015) N-methyl-D-aspartic acid receptor 1 (NMDAR1) aggravates secondary inflammatory damage induced by hemin-NLRP3 pathway after intracerebral hemorrhage. Chin J Traumatol 18:254–258CrossRefPubMedGoogle Scholar
  140. Wutzler S et al (2009) Suppression and recovery of LPS-stimulated monocyte activity after trauma is correlated with increasing injury severity: a prospective clinical study. J Trauma 66:1273–1280. Scholar
  141. Wutzler S, Lustenberger T, Relja B, Lehnert M, Marzi I (2013) Pathophysiology of multiple trauma: intensive care medicine and timing of treatment. Chirurg 84:753–758. Scholar
  142. Xiang M et al (2011) Hemorrhagic shock activation of NLRP3 inflammasome in lung endothelial cells. J Immunol 187:4809–4817. Scholar
  143. Xiao W et al (2011) A genomic storm in critically injured humans. J Exp Med 208:2581–2590. Scholar
  144. Xiao M et al (2016) 3,4-Methylenedioxy-beta-nitrostyrene ameliorates experimental burn wound progression by inhibiting the NLRP3 inflammasome activation. Plast Reconstr Surg 137:566e–575e. Scholar
  145. Yamasaki K et al (2009) NLRP3/cryopyrin is necessary for interleukin-1beta (IL-1beta) release in response to hyaluronan, an endogenous trigger of inflammation in response to injury. J Biol Chem 284:12762–12771. Scholar
  146. Yang F et al (2014) NLRP3 deficiency ameliorates neurovascular damage in experimental ischemic stroke. J Cereb Blood Flow Metab 34:660–667. Scholar
  147. Yang J et al (2016) Hemorrhagic shock primes for lung vascular endothelial cell pyroptosis: role in pulmonary inflammation following LPS. Cell Death Dis 7:e2363. Scholar
  148. Yang J, Liu Z, Xiao TS (2017) Post-translational regulation of inflammasomes. Cell Mol Immunol 14:65–79. Scholar
  149. Yuan B et al (2015) Recombinant adenovirus encoding NLRP3 RNAi attenuate inflammation and brain injury after intracerebral hemorrhage. J Neuroimmunol 287:71–75. Scholar
  150. Zedler S, Faist E (2006) The impact of endogenous triggers on trauma-associated inflammation. Curr Opin Crit Care 12:595–601. Scholar
  151. Zhang AQ et al (2011) Clinical relevance of single nucleotide polymorphisms within the entire NLRP3 gene in patients with major blunt trauma. Crit Care 15:R280. Scholar
  152. Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J (2010) Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 11:136–140. Scholar
  153. Zhu P et al (2011) Gene silencing of NALP3 protects against liver ischemia-reperfusion injury in mice. Hum Gene Ther 22:853–864. Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Trauma, Hand and Reconstructive SurgeryUniversity Hospital Frankfurt, Goethe UniversityFrankfurt am MainGermany
  2. 2.Department of Psychiatry and PsychotherapyUniversity Medicine MainzMainzGermany

Personalised recommendations